Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils

Guy Brusselle, Matthew Germinaro, Sherrine Eid, James Zangrilli
European Respiratory Journal 2015 46: OA287; DOI: 10.1183/13993003.congress-2015.OA287
Guy Brusselle
1Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Germinaro
2Global Respiratory Research and Development, Teva Pharmaceuticals, Frazer, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherrine Eid
3Biostatistics, Teva Pharmaceuticals, Frazer, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Zangrilli
4Global Respiratory Research and Development, Global Branded Products, Teva Pharmaceuticals, Frazer, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 46 no. suppl 59
DOI 
https://doi.org/10.1183/13993003.congress-2015.OA287

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online October 30, 2015.

Copyright & Usage 
Copyright ©ERS 2015

Author Information

  1. Guy Brusselle1,
  2. Matthew Germinaro2,
  3. Sherrine Eid3 and
  4. James Zangrilli4
  1. 1Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
  2. 2Global Respiratory Research and Development, Teva Pharmaceuticals, Frazer, United States
  3. 3Biostatistics, Teva Pharmaceuticals, Frazer, United States
  4. 4Global Respiratory Research and Development, Global Branded Products, Teva Pharmaceuticals, Frazer, United States

Article usage

Article usage: November 2015 to May 2022

AbstractFullPdf
Nov 20154400
Dec 20152200
Jan 20161500
Feb 201614026
Mar 20162000
Apr 20162500
May 20162500
Jun 20162000
Jul 20161700
Aug 20162800
Sep 201630017
Oct 20163400
Nov 20164700
Dec 201631034
Jan 20171700
Feb 20172600
Mar 20171400
Apr 20171800
May 20171100
Jun 2017800
Jul 20171900
Aug 20171100
Sep 20171400
Oct 2017800
Nov 2017700
Dec 20171400
Jan 20181400
Feb 20181700
Mar 2018900
Apr 2018800
May 20181000
Jun 2018900
Jul 2018200
Aug 2018500
Sep 20181000
Oct 20181200
Nov 20181300
Dec 20181700
Jan 2019600
Feb 20191000
Mar 2019400
Apr 2019900
May 2019300
Jun 2019600
Jul 20191000
Aug 2019500
Sep 2019300
Oct 2019600
Nov 2019500
Dec 2019500
Jan 2020700
Feb 20201100
Mar 20201000
Apr 20201300
May 2020400
Jun 2020400
Jul 2020700
Aug 2020700
Sep 2020500
Oct 2020400
Nov 20201200
Dec 20201300
Jan 2021300
Feb 20211000
Mar 2021600
Apr 2021500
May 2021500
Jun 2021400
Jul 2021600
Aug 2021600
Sep 2021700
Oct 2021700
Nov 20213000
Dec 20211600
Jan 20222400
Feb 2022300
Mar 2022500
Apr 2022600
May 2022300

Altmetrics

Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils
Guy Brusselle, Matthew Germinaro, Sherrine Eid, James Zangrilli
European Respiratory Journal Sep 2015, 46 (suppl 59) OA287; DOI: 10.1183/13993003.congress-2015.OA287

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils
Guy Brusselle, Matthew Germinaro, Sherrine Eid, James Zangrilli
European Respiratory Journal Sep 2015, 46 (suppl 59) OA287; DOI: 10.1183/13993003.congress-2015.OA287
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Pharmacological characterization of the anti-oxidant activity of N-acetylcysteine in an ex vivo model of COPD exacerbation
  • TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics
  • Neurokinin-1 receptor antagonism for the treatment of cough in lung cancer
Show more 5.1 Airway Pharmacology and Treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society